Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hair loss as a result of chemotherapy treatment.
Biomarker and diagnostic research for chemotherapy-induced alopecia has been reported in the published literature.
11 clinical trials registered, 5 recruiting. Interventions under study include medical devices, drug therapy, and other interventions. Pipeline includes 2 PHASE2, 1 EARLY_PHASE1, 8 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04986579](https://clinicaltrials.gov/study/NCT04986579) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Scalp Cooling in MBC |
PHASE2 |
Dana-Farber Cancer Institute |
RECRUITING |
[NCT07422376](https://clinicaltrials.gov/study/NCT07422376) | Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region | NA | Charles Mays | RECRUITING |
[NCT05177289](https://clinicaltrials.gov/study/NCT05177289) | Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia | NA | Jessa Hospital | RECRUITING |
[NCT05213936](https://clinicaltrials.gov/study/NCT05213936) | Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color | NA | Montefiore Medical Center | RECRUITING |
[NCT05484973](https://clinicaltrials.gov/study/NCT05484973) | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss | NA | Cooler Heads Care Inc. | RECRUITING |
95 publications have been identified in PubMed for chemotherapy-induced alopecia. Research spans Basic Science / Preclinical (32%), Clinical Trial Publication (22%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 30 | 32% |
Clinical study results | 21 | 22% |
Disease patterns and progression | 14 | 15% |
Research summaries | 13 | 14% |
Other research | 5 | 5% |
Patient case studies | 5 | 5% |
New treatment approaches | 4 | 4% |
Testing and diagnosis research | 3 | 3% |
Saleh D (2026). [PMID: 29493918](https://pubmed.ncbi.nlm.nih.gov/29493918/). *Unknown Journal*. [Other]
Garza-Rodríguez V (2026). [PMID: 41999877](https://pubmed.ncbi.nlm.nih.gov/41999877/). *Actas Dermosifiliogr*. [Review / Meta-Analysis]
Li T (2026). [PMID: 42190537](https://pubmed.ncbi.nlm.nih.gov/42190537/). *Bioorg Chem*. [Basic Science / Preclinical]
Minta A (2026). [PMID: 42084781](https://pubmed.ncbi.nlm.nih.gov/42084781/). *Support Care Cancer*. [Epidemiology / Natural History]
Zheng M (2026). [PMID: 42190499](https://pubmed.ncbi.nlm.nih.gov/42190499/). *Biomed Pharmacother*. [Basic Science / Preclinical]
Ouyang Y (2026). [PMID: 41836915](https://pubmed.ncbi.nlm.nih.gov/41836915/). *Clinicoecon Outcomes Res*. [Gene Therapy / Novel Therapeutics]
Wang PC (2026). [PMID: 42196158](https://pubmed.ncbi.nlm.nih.gov/42196158/). *Int J Mol Sci*. [Review / Meta-Analysis]
El-Din AA (2026). [PMID: 41371370](https://pubmed.ncbi.nlm.nih.gov/41371370/). *Toxicol Appl Pharmacol*. [Basic Science / Preclinical]
Kwok ST (2026). [PMID: 41851427](https://pubmed.ncbi.nlm.nih.gov/41851427/). *Sci Rep*. [Clinical Trial Publication]
Manchanda R (2026). [PMID: 40876091](https://pubmed.ncbi.nlm.nih.gov/40876091/). *Biomaterials advances*. [Gene Therapy / Novel Therapeutics]